SARS-CoV-2 Neutralizing Nanobodies
US Application 63/151,530
Filed on 2021-02-19
Filed on 2021-02-19
Compounds, Compositions, and Methods for Treating And/Or Preventing Periodontal Disease
US Application 62/590,824
Filed on 2017-11-27
Filed on 2017-11-27
Antibodies to Hepatitis B E-Antigen And Diagnostic and Therapeutic Uses Thereof
US Application 62/534,603
Filed on 2017-07-19
Filed on 2017-07-19
Regulatory Genetic Variants of IL1RN
US Application 62/549,746
Filed on 2017-08-24
Filed on 2017-08-24
ENGINEERING NEURAL STEM CELLS USING HOMOLOGOUD RECOMBINATION
US Application 61/904,999
Filed on 2013-11-15
Filed on 2013-11-15
Compositions for Modification of Genomic DNA and Exogenous Gene Expression and Related Applications
US Application 61/905,002
Filed on 2013-11-15
Filed on 2013-11-15
TNFalpha-mediated Cleavage And Inactivation Of SIRT1 In Human Chondrocytes
US Application 61/474,351
Filed on 2011-04-12
Filed on 2011-04-12
Blockade of TL1A-DR3 Interactions To Ameliorate T Cell Mediated Disease Pathology And Antibodies Thereof
US Application 61/488,671
Filed on 2011-05-20
Filed on 2011-05-20
Generation And Use Fab, SCFV, And Related Binding Molecules Specific For HIV-1 Rev
US Application 61/439,307
Filed on 2011-02-03
Filed on 2011-02-03
A nanofiberous conduit seeded with muscle-derived mesenchymal progenitor cells
US Application 61/117,814
Filed on 2008-11-25
Filed on 2008-11-25